A stem cell therapy market forecast report has projected that orthopedic segment is estimated to observe more than 9% growth rate over 2019-2025. The growth of orthopedic stem cell industry share can be accredited to increase in number of trauma and accidents cases across the globe. Stem cell therapy has successfully found its application in treatment of bone-joint injuries which include fractured bone and spinal defects, femoral head, osteogenesis imperfecta, and ligament tendon.
Intensifying research on evolving innovative therapies and modified medicines is likely to bolster stem cell therapy market size growth. Scientists have been reportedly seeking the methods to regenerate healthy heart cells from placenta which can be used in patients following myocardial infarction. The discovery may help patients with cardiovascular diseases and lessen mortality rates.
Get sample copy of this research report @ https://www.decresearch.com/request-sample/detail/3331
In terms of the application scope, orthopedic segment has gained considerable recognition due to the increasing cases of accidents and traumas worldwide. Stem cell therapies are popularly used in treating bone-joint injuries such as fractured bone defects, ligament tendon, osteogenesis imperfecta, and femoral head, and many others.
Geographically speaking, Europe stem cell therapy market share has witnessed considerable gains over the last few of years due to the growing prevalence of chronic diseases in the region. Additionally, increasing awareness among people with respect to the advantages associated with the therapy is magnifying the market reach.
The need for specialized treatments has subsequently led to the development of specialty clinics that offer targeted treatment. These clinics are equipped with innovative medical devices and skilled professionals that extend superior quality stem cell therapies. Clinics also carry the ability to offer specialized stem cell treatment in the treatment of cardiovascular diseases, orthopedics, and oncology.
There are several prominent market players partaking in stem cell therapy industry share including Cellectis, Astellas Pharma, Celyad, Gamida Cell, ReNeuron Group, Capricor Therapeutics, Novadip Biosciences, Cellular Dynamics, CESCA Therapeutics, OxStem, Mesoblast, Takeda Pharmaceuticals, and DiscGenics.
Request for customization @ https://www.decresearch.com/roc/3331
Partial Chapter of the Table of Content
Chapter 4. Stem Cell Therapy Market, By Type
4.1. Key segment trends
4.2. Allogenic stem cell therapy
4.2.1. Market size, by region, 2014-2025 (USD Million)
4.3. Autologous stem cell therapy
4.3.1. Market size, by region, 2014-2025 (USD Million)
Chapter 5. Stem Cell Therapy Market, By Application
5.1. Key segment trends
5.2. Oncology
5.2.1. Market size, by region, 2014-2025 (USD Million)
5.3. Orthopedic
5.3.1. Market size, by region, 2014-2025 (USD Million)
5.4. Cardiovascular
5.4.1. Market size, by region, 2014-2025 (USD Million)
5.5. Neurology
5.5.1. Market size, by region, 2014-2025 (USD Million)
5.6. Others
5.6.1. Market size, by region, 2014-2025 (USD Million)
Chapter 6. Stem Cell Therapy Market, By End-users
6.1. Key segment trends
6.2. Hospitals
6.2.1. Market size, by region, 2014-2025 (USD Million)
6.3. Clinics
6.3.1. Market size, by region, 2014-2025 (USD Million)
6.4. Others
6.4.1. Market size, by region, 2014-2025 (USD Million)
Browse full table of contents (TOC) of this report @ https://www.decresearch.com/toc/detail/stem-cell-therapy-market
Recommendation and review posted by G. Smith
